PROCESS FOR PRODUCTION OF MEDICAL COMPOSITIONS BASED ON SINERGETIC MUTUAL INFLUENCE OF LIMFOCINES AND TWO-FADED RNA

摘要

A prod. contg. dsRNA and a lymphokine is claimed as a combined prepn. for simultaneous, separate or sequential use in the treatment of tumour, virus-infected or immune-disregulated cells. The lymphokine is pref. alpha interferon or interleukin 2 (IL-2). The prod. pref. comprises mismatched dsRNA in amt. sufficient to result in a level of 0.01-1000 microgram/ml of the patient's body fluid and IL-2 in an amt. sufficient to result in a level of 100-1 million IL-2 units/kg of the patient's wt.